Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract P192: Lipoprotein(a) is Significantly Associated with ApoB-containing Atherogenic Lipoproteins in African Americans

View through CrossRef
Background: Lipoprotein(a), Lp(a), is a genetically regulated independent cardiovascular risk factor, where levels differ across ethnicity. The relationship between Lp(a) and apolipoprotein B (apoB)-containing atherogenic lipoproteins across ethnicity is not well understood. Objective: To investigate the associations of Lp(a) levels with other apoB-containing lipoproteins with a focus on ethnicity. Methods: Plasma lipid and lipoproteins were measured in 336 Caucasians and 224 African Americans undergoing coronary angiography. Lp(a) levels were determined using an apo(a) size insensitive sandwich ELISA. Values for Lp(a) and triglyceride (TG) were square root or logarithmically transformed before analyses. Total and low density lipoprotein (LDL) cholesterol, and apoB levels were corrected for contribution of Lp(a) using previously published algorithms. Values are given mean ± standard deviation or median (interquartile range) for normally or non-normally distributed variables, respectively. Results: Levels of total and LDL cholesterol and apoB-100 did not differ between Caucasians and African Americans. As expected, African Americans had significantly higher levels of Lp(a) [110 (60-180) nmol/l vs. 24 (7-79) nmol/l, p<0.001] and high density lipoprotein (HDL) cholesterol (49±17 mg/dl vs. 41±12 mg/dl, p<0.001), as well as significantly lower levels of TG [106 (80-144) mg/dl vs. 153 (114-222) mg/dl, p<0.001] compared to Caucasians. For both ethnic groups, Lp(a) levels were significantly and positively correlated with total cholesterol (p<0.005 for Caucasians and p<0.001 for African Americans), LDL cholesterol (p<0.001 for both groups), apoB100 (p<0.05 for Caucasians and p<0.001 for African Americans) and apoB/apoA-1 ratio (p<0.05 for Caucasians and p<0.001 for African Americans). However, when adjusted for the corresponding contribution of Lp(a) to the levels of these parameters, the associations remained significant in African Americans (p<0.05 for total cholesterol; p<0.05 for LDL cholesterol; p<0.001 for apoB100, respectively), but not in Caucasians. Conclusion: Although total and LDL cholesterol, and apoB100 levels were comparable in African Americans and Caucasians, the associations of these parameters with Lp(a) levels differed across ethnicity. For African Americans, but not for Caucasians, associations of all three parameters with Lp(a) remained significant after appropriate adjustments. The findings suggest an interethnic difference in the relation between Lp(a) and other plasma apoB-containing lipoprotein levels, with a closer relationship among African Americans.
Title: Abstract P192: Lipoprotein(a) is Significantly Associated with ApoB-containing Atherogenic Lipoproteins in African Americans
Description:
Background: Lipoprotein(a), Lp(a), is a genetically regulated independent cardiovascular risk factor, where levels differ across ethnicity.
The relationship between Lp(a) and apolipoprotein B (apoB)-containing atherogenic lipoproteins across ethnicity is not well understood.
Objective: To investigate the associations of Lp(a) levels with other apoB-containing lipoproteins with a focus on ethnicity.
Methods: Plasma lipid and lipoproteins were measured in 336 Caucasians and 224 African Americans undergoing coronary angiography.
Lp(a) levels were determined using an apo(a) size insensitive sandwich ELISA.
Values for Lp(a) and triglyceride (TG) were square root or logarithmically transformed before analyses.
Total and low density lipoprotein (LDL) cholesterol, and apoB levels were corrected for contribution of Lp(a) using previously published algorithms.
Values are given mean ± standard deviation or median (interquartile range) for normally or non-normally distributed variables, respectively.
Results: Levels of total and LDL cholesterol and apoB-100 did not differ between Caucasians and African Americans.
As expected, African Americans had significantly higher levels of Lp(a) [110 (60-180) nmol/l vs.
24 (7-79) nmol/l, p<0.
001] and high density lipoprotein (HDL) cholesterol (49±17 mg/dl vs.
41±12 mg/dl, p<0.
001), as well as significantly lower levels of TG [106 (80-144) mg/dl vs.
153 (114-222) mg/dl, p<0.
001] compared to Caucasians.
For both ethnic groups, Lp(a) levels were significantly and positively correlated with total cholesterol (p<0.
005 for Caucasians and p<0.
001 for African Americans), LDL cholesterol (p<0.
001 for both groups), apoB100 (p<0.
05 for Caucasians and p<0.
001 for African Americans) and apoB/apoA-1 ratio (p<0.
05 for Caucasians and p<0.
001 for African Americans).
However, when adjusted for the corresponding contribution of Lp(a) to the levels of these parameters, the associations remained significant in African Americans (p<0.
05 for total cholesterol; p<0.
05 for LDL cholesterol; p<0.
001 for apoB100, respectively), but not in Caucasians.
Conclusion: Although total and LDL cholesterol, and apoB100 levels were comparable in African Americans and Caucasians, the associations of these parameters with Lp(a) levels differed across ethnicity.
For African Americans, but not for Caucasians, associations of all three parameters with Lp(a) remained significant after appropriate adjustments.
The findings suggest an interethnic difference in the relation between Lp(a) and other plasma apoB-containing lipoprotein levels, with a closer relationship among African Americans.

Related Results

Abstract 3404: Clinical significance of APOB inactivation in hepatocellular carcinoma
Abstract 3404: Clinical significance of APOB inactivation in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the seventh most common cancer and second the most lethal cancer globally. 5-year OS rates in US are only 11%. Sequencing ...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Differential distribution of plasma apoA-I and apoB levels and clinical significance of apoB/apoA-I ratio in ischemic stroke subtypes
Differential distribution of plasma apoA-I and apoB levels and clinical significance of apoB/apoA-I ratio in ischemic stroke subtypes
Background and purposeIschemic stroke (IS) is classified into clinical subtypes and likely influenced by various lipid components. Nevertheless, the roles of apolipoprotein A-I (ap...
Abstract 3041: APOB Gene Deletion Increases The Expression Of Vitamin D Binding Protein In Human Hepatoma Cells
Abstract 3041: APOB Gene Deletion Increases The Expression Of Vitamin D Binding Protein In Human Hepatoma Cells
High plasma apolipoprotein B (apoB)-containing lipoproteins are both a biomarker and a causal mediator of many metabolic diseases. Inhibition of APOB mRNA decreases plasma lipid le...
The Association Between apolipoprotein B and Risk of Cardiovascular Disease:Mendelian randomization analysis
The Association Between apolipoprotein B and Risk of Cardiovascular Disease:Mendelian randomization analysis
Abstract Background: The threat of cardiovascular disease looms large across the globe and poses a significant risk to people's lives. One of the primary culprits causing ...
Recent advances in physiological lipoprotein metabolism
Recent advances in physiological lipoprotein metabolism
AbstractResearch into lipoprotein metabolism has developed because understanding lipoprotein metabolism has important clinical indications. Lipoproteins are risk factors for cardio...

Back to Top